• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受维持性持续不卧床腹膜透析的终末期肾病患者中,72 小时血糖谱评估中的连续血糖监测系统。

Continuous glucose monitoring system in 72-hour glucose profile assessment in patients with end-stage renal disease on maintenance continuous ambulatory peritoneal dialysis.

机构信息

Department of Internal Medicine, Diabetology and Nephrology, Medical University of Silesia, Zabrze, Poland.

出版信息

Med Sci Monit. 2010 Feb;16(2):CR75-83.

PMID:20110918
Abstract

BACKGROUND

Glucose has been the main osmole used in conventional peritoneal fluids (PDFs) since the beginning of continuous ambulatory peritoneal dialysis (CAPD). There is much concern regarding the possible risk to the good level of glycemia control lately observed. The aim of this study was to analyze, with the use of 72-hour continuous glucose monitoring system (CGMS), the influence of PDFs containing supra-physiological glucose concentrations on daily glucose profile in patients with end stage renal disease (ESRD) undergoing CAPD therapy.

MATERIAL/METHODS: There were 30 diabetic and non-diabetic patients on CAPD using conventional 1.36% or 2.27% glucose PDFs examined in the study, with a control group of 13 healthy volunteers. All participants underwent 72-hour CGMS and HbA1c evaluation. There was the whole area under the curve (AUC) of each 24-hour glucose profile and of glucose excursion above 90 mg/dl estimated.

RESULTS

The high transport status appeared to significantly influence the mean maximum glucose value and its increment following peritoneal exchange (PE) in the study group and in a subgroup of diabetic patients, whereas in non-diabetics the mean 24-hour glucose concentration was importantly influenced. The percentage of glucose levels in the range above 90 mg/dl was significantly influenced by higher glucose concentration in the PDFs, as well as higher peritoneal transport status.

CONCLUSIONS

The outcomes indicate that dialysate glucose concentration, as well as type of peritoneal transport, influence the occurrence of persistent hyperglycemia state, and suggest that CAPD may predispose to appearance of glycemic disorders.

摘要

背景

自持续非卧床腹膜透析(CAPD)开始以来,葡萄糖一直是传统腹膜液(PDF)中主要的渗透溶质。最近人们非常担心这可能会对良好的血糖控制水平造成风险。本研究旨在使用 72 小时连续血糖监测系统(CGMS)分析含有超生理浓度葡萄糖的 PDF 对接受 CAPD 治疗的终末期肾病(ESRD)患者日常血糖谱的影响。

材料/方法:研究共检查了 30 名使用传统 1.36%或 2.27%葡萄糖 PDF 的糖尿病和非糖尿病 CAPD 患者,对照组为 13 名健康志愿者。所有参与者均接受了 72 小时 CGMS 和 HbA1c 评估。估计了每个 24 小时血糖谱的总曲线下面积(AUC)以及血糖超过 90mg/dl 的葡萄糖波动幅度。

结果

高转运状态似乎明显影响了研究组和糖尿病患者亚组中每个 24 小时葡萄糖平均值及其腹膜交换(PE)后的增量,而在非糖尿病患者中,24 小时平均葡萄糖浓度受到重要影响。血糖水平在 90mg/dl 以上的百分比受到 PDF 中葡萄糖浓度较高以及腹膜转运状态较高的显著影响。

结论

研究结果表明,透析液葡萄糖浓度以及腹膜转运类型会影响持续高血糖状态的发生,并表明 CAPD 可能会导致血糖紊乱的发生。

相似文献

1
Continuous glucose monitoring system in 72-hour glucose profile assessment in patients with end-stage renal disease on maintenance continuous ambulatory peritoneal dialysis.在接受维持性持续不卧床腹膜透析的终末期肾病患者中,72 小时血糖谱评估中的连续血糖监测系统。
Med Sci Monit. 2010 Feb;16(2):CR75-83.
2
The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.非糖尿病终末期肾病患者血液透析和持续性非卧床腹膜透析时胰岛素敏感性的测定
Saudi Med J. 2005 May;26(5):786-91.
3
The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.生物相容性碳酸氢盐腹膜透析液条件下透析液中癌抗原125浓度的变化及间皮细胞活力的维持。
Ren Fail. 2008;30(2):161-7. doi: 10.1080/08860220701808384.
4
Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.腹膜转运状态对持续性非卧床腹膜透析患者动脉粥样硬化/炎症的影响。
J Ren Nutr. 2005 Oct;15(4):427-34. doi: 10.1053/j.jrn.2005.07.007.
5
Continuous interstitial glucose monitoring in non-diabetic subjects with end-stage renal disease undergoing maintenance haemodialysis.非糖尿病终末期肾病维持性血液透析患者的连续间质葡萄糖监测。
Diabetes Res Clin Pract. 2010 Oct;90(1):22-5. doi: 10.1016/j.diabres.2010.06.001. Epub 2010 Aug 11.
6
Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.台湾接受血液透析和持续性非卧床腹膜透析患者的血浆游离氨基酸及其代谢产物
Clin Chim Acta. 2006 Feb;364(1-2):209-16. doi: 10.1016/j.cccn.2005.07.001. Epub 2005 Aug 8.
7
Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.非糖尿病和糖尿病患者持续性非卧床腹膜透析期间天然胰岛素透过腹膜的情况。
Adv Perit Dial. 1995;11:119-22.
8
Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.持续性非卧床腹膜透析(CAPD)开始时糖尿病患者与非糖尿病患者之间液体和溶质转运的差异。
Adv Perit Dial. 1997;13:29-32.
9
Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.持续非卧床腹膜透析或自动化腹膜透析治疗儿童的残余肾功能——一项初步研究。
Adv Perit Dial. 2009;25:103-9.
10
Impact of introduction of continuous ambulatory peritoneal dialysis on blood pressure: analysis of 24-hour ambulatory blood pressure.持续非卧床腹膜透析的引入对血压的影响:24小时动态血压分析
Adv Perit Dial. 2000;16:97-101.

引用本文的文献

1
Scoping Review-Diabetes Technology for Individuals on Kidney Replacement Therapy (Dialysis): Current Trends and Future Directions.范围综述——肾脏替代治疗(透析)患者的糖尿病技术:当前趋势与未来方向
J Diabetes Sci Technol. 2025 Sep 2:19322968251353811. doi: 10.1177/19322968251353811.
2
Glycemic Control in Patients with Diabetes on Peritoneal Dialysis: From Glucose Sparing Approach to Glucose Monitoring.腹膜透析糖尿病患者的血糖控制:从节约葡萄糖方法到血糖监测
Life (Basel). 2025 May 17;15(5):798. doi: 10.3390/life15050798.
3
Peritoneal Dialysis Care for People with Diabetes, Polycystic Kidney Disease, or Advanced Liver Disease.
糖尿病、多囊肾病或晚期肝病患者的腹膜透析护理
Clin J Am Soc Nephrol. 2025 Jan 1;20(1):139-146. doi: 10.2215/CJN.0000000000000420. Epub 2024 Jan 8.
4
Performance of Dexcom G5 and FreeStyle Libre sensors tested simultaneously in people with type 1 or 2 diabetes and advanced chronic kidney disease.德康G5和免校准连续血糖监测系统传感器在1型或2型糖尿病合并晚期慢性肾病患者中的同步测试性能
World J Clin Cases. 2022 Aug 6;10(22):7794-7807. doi: 10.12998/wjcc.v10.i22.7794.
5
Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.使用连续血糖监测评估和管理糖尿病及慢性肾脏病患者。
Front Endocrinol (Lausanne). 2022 Apr 22;13:869899. doi: 10.3389/fendo.2022.869899. eCollection 2022.
6
Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.血糖监测与管理在慢性肾脏病晚期中的应用。
Endocr Rev. 2020 Oct 1;41(5):756-74. doi: 10.1210/endrev/bnaa017.
7
Skin Autofluorescence and Mortality in Patients on Peritoneal Dialysis.腹膜透析患者的皮肤自发荧光与死亡率
Medicine (Baltimore). 2015 Nov;94(45):e1933. doi: 10.1097/MD.0000000000001933.
8
Recent advances in the management of peritoneal dialysis patients.腹膜透析患者管理的最新进展
F1000Prime Rep. 2015 May 1;7:57. doi: 10.12703/P7-57. eCollection 2015.
9
Should glucose-sparing prescriptions be expected to reduce the cardiovascular risk of peritoneal dialysis patients?节约葡萄糖的处方有望降低腹膜透析患者的心血管风险吗?
J Am Soc Nephrol. 2013 Nov;24(11):1713-6. doi: 10.1681/ASN.2013080823. Epub 2013 Aug 29.